Published in Int J Gynecol Cancer on June 28, 2006
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol (2007) 1.66
Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia. PLoS One (2013) 1.45
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med (2011) 1.23
Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infect Dis (2013) 0.97
Prevalence and Distribution of High-Risk Genotypes of HPV in Women with Severe Cervical Lesions in Madrid, Spain: Importance of Detecting Genotype 16 and Other High-Risk Genotypes. Adv Prev Med (2010) 0.86
Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide. PLoS One (2014) 0.85
Human papillomavirus typing of invasive cervical cancers in Italy. Infect Agent Cancer (2006) 0.82
Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand. BMC Infect Dis (2014) 0.78
Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 4.76
An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum (2008) 4.25
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 3.25
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum (2006) 3.03
Fourier transform infrared (FTIR) spectral mapping of the cervical transformation zone, and dysplastic squamous epithelium. Gynecol Oncol (2004) 2.75
Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 2.47
The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis. BJOG (2011) 2.32
A self-administered technique for the detection of sexually transmitted diseases in remote communities. J Infect Dis (1997) 1.95
Tampons and toxic shock syndrome. Med J Aust (1995) 1.94
Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. Sex Transm Infect (1999) 1.83
Validation of roche COBAS Amplicor assay for detection of Chlamydia trachomatis in rectal and pharyngeal specimens by an omp1 PCR assay. J Clin Microbiol (2004) 1.66
Comparison of conventional testing to polymerase chain reaction in detection of Trichomonas vaginalis in indigenous women living in remote areas. Int J STD AIDS (2005) 1.60
The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis (2006) 1.55
Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.54
Is there any value in bimanual pelvic examination as a screening test. Med J Aust (1995) 1.52
Field evaluation of the CRT and ACON chlamydia point-of-care tests in a tropical, low-resource setting. Sex Transm Infect (2013) 1.50
A solid-phase enzyme-linked immunosorbent assay (ELISA) for detection of antibody to rubella virus. Pathology (1979) 1.48
Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed (2006) 1.47
Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis (1992) 1.44
Human papillomavirus vulvitis: a new disease or an unfortunate mistake? Br J Obstet Gynaecol (1994) 1.39
Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect (2009) 1.37
Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay. Sex Transm Infect (2004) 1.30
Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis (2002) 1.27
Alcohol problems in acute male medical admissions. Health Bull (Edinb) (1976) 1.25
The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women. Sex Transm Infect (1998) 1.25
Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women. Int J STD AIDS (1998) 1.24
Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer (2000) 1.23
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer (2004) 1.23
Evaluation of new Granada medium (modified) for the antenatal screening of group B streptococcus. Pathology (1994) 1.20
The absence of genital human papillomavirus DNA in virginal women. Int J STD AIDS (1993) 1.20
Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A virus. J Clin Microbiol (1978) 1.19
Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol (1995) 1.18
Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia. Infect Dis Obstet Gynecol (2001) 1.16
Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol (2005) 1.16
FTIR microspectroscopic study of cell types and potential confounding variables in screening for cervical malignancies. Biospectroscopy (1998) 1.16
Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis (2005) 1.16
Differing Neisseria gonorrhoeae bacterial loads in the pharynx and rectum in men who have sex with men: implications for gonococcal detection, transmission, and control. J Clin Microbiol (2011) 1.14
Candida albicans: is it associated with nipple pain in lactating women? Gynecol Obstet Invest (1996) 1.13
Simplified culture procedure for large-scale screening for Chlamydia trachomatis infections. J Clin Microbiol (1988) 1.12
Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. Br J Cancer (1982) 1.10
A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR. Sex Transm Infect (2005) 1.10
Detection of cervical intraepithelial neoplasia in vivo using confocal endomicroscopy. BJOG (2009) 1.09
The contribution of spirituality and spiritual coping to anxiety and depression in women with a recent diagnosis of gynecological cancer. Int J Gynecol Cancer (2005) 1.08
A comparison of cytobrush and cotton swab sampling for the detection of Chlamydia trachomatis by cell culture. Genitourin Med (1990) 1.07
The impact of ultrasonography on diagnosis and management of patients with musculoskeletal conditions. Arthritis Rheum (2001) 1.06
Molecular epidemiology of coagulase-negative staphylococcal bacteraemia in a newborn intensive care unit. J Hosp Infect (2002) 1.06
Comparison of a DNA probe assay with culture for the detection of Chlamydia trachomatis. J Med Microbiol (1991) 1.05
Human papillomavirus in corneal and conjunctival carcinoma. Aust N Z J Ophthalmol (1997) 1.02
Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.02
An outreach programme for sexually transmitted infection screening in street sex workers using self-administered samples. Int J STD AIDS (1999) 1.02
Evaluation of patient-administered tampon specimens for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis (2000) 1.02
Progestogen treatment options for early endometrial cancer. BJOG (2010) 1.02
Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting. J Clin Virol (2001) 1.01
Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. Br J Cancer (2005) 1.01
Rotational delivery of the fetus: Kielland's forceps and two other methods compared. Br J Obstet Gynaecol (1982) 1.00
Sexually transmitted diseases in disadvantaged Australian communities. JAMA (1997) 1.00
Patient-administered tampon-collected genital cells in the assessment of Chlamydia trachomatis infection using polymerase chain reaction. Sex Transm Dis (1997) 0.99
True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha? Ann Rheum Dis (2004) 0.99
Isolation of genital mycoplasmas from the blood of neonates and women with pelvic infection using conventional SPS-free blood culture media. Pathology (1987) 0.98
Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling. Sex Transm Infect (2005) 0.98
Clear-cell cancer of the ovary-is it chemosensitive? Int J Gynecol Cancer (2005) 0.97
Successful treatment of mother and baby with metastatic choriocarcinoma. Int J Gynecol Cancer (2002) 0.96
Prevalence and genotyping of HPV in cervical cancer among Australian women. Int J Gynaecol Obstet (1999) 0.96
False positivity with third-generation (monoclonal) assay for hepatitis B surface antigen. Lancet (1988) 0.95
Juvenile laryngeal papillomatosis in a pediatric population: a clinicopathologic study. Pediatr Pathol Lab Med (1997) 0.95
Detection of genital human papillomavirus (HPV) DNA by PCR and other conventional hybridisation techniques in male partners of women with abnormal Papanicolaou smears. Genitourin Med (1992) 0.95
Impact of erythromycin on respiratory colonization of Ureaplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants. Pediatr Infect Dis J (1998) 0.94
Will the legalisation of street sex work improve health? Sex Transm Infect (2002) 0.94
Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment. Nephrol Dial Transplant (1994) 0.93
Cryptic-plasmid-free gonococci may contribute to failure of cppB gene-based assays to confirm results of BD ProbeTEC PCR for identification of Neisseria gonorrhoeae. J Clin Microbiol (2005) 0.93
Bacteraemia and pelvic infection in women due to Ureaplasma urealyticum and Mycoplasma hominis. Med J Aust (1987) 0.93
Factors influencing serum CA 125 levels in normal women. Obstet Gynecol (1992) 0.91
An immunohistochemical perspective of PPAR beta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours. Br J Cancer (2008) 0.91
Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice. Gynecol Oncol (2004) 0.91
Differential expression of the alpha(2)-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma. Mol Hum Reprod (2000) 0.91
Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 0.90
Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex Transm Infect (2003) 0.90
Mycoplasma genitalium in men who have sex with men at male-only saunas. Sex Transm Infect (2009) 0.89
An improved tripod amphiphile for membrane protein solubilization. Protein Sci (2000) 0.89